Literature DB >> 1098376

Malignant lymphomas of the nervous system.

H M Zimmerman.   

Abstract

In a series of some 7,000 patients with tumors of the central nervous system, 208 patients (about 3%) had some form of a malignant lymphoma. Slightly less than half of these tumors were primary in the brain; the remainder had cranial involvement as part of a generalized process. The tumors consisted of Hodgkin's disease, lymphosarcomas, reticulosarcomas and plasmacytomas. The brain was involved in one of two ways: either as localized tumor masses resembling certain gliomas, or as diffusely invasive neoplasms resembling exudative cellular inflammatory processes. They had a peculiar predilection for the septum pellucidum but occurred also in the cerebral lobes, basal ganglia, brain stem and cerebellum. They all produced a fibrillary stroma of reticulin fibers and they spread along the perivascular spaces, in the cerebrospinal subarachnoid space, or intraventricularly on and beneath the ependymal lining. One type of lymphoma often fused into another - thus a single tumor often consisted of Hodgkin's sarcoma, lymphosarcoma and reticulosarcoma. In an addition series of 57 cases of spinal cord involvement by malignant lymphomas, there were no instances of a primary tumor; all patients had either primary lymphomas of the brain with secondary spread to the spinal subarchnoid space, or had spinal cord compression as a result of tumor in the vertebrae, the spinal epidural space, or the spinal dura. Hence the spinal cord involvement was a secondary manifestation of a lymphoma elsewhere. Peripheral nerve involvement by lymphomas resulted in destruction of myelin sheaths and axons by tumor cell infiltration and the neuropathy was always part of a generalized lymphomatosis.

Entities:  

Mesh:

Year:  1975        PMID: 1098376     DOI: 10.1007/978-3-662-08456-4_11

Source DB:  PubMed          Journal:  Acta Neuropathol Suppl        ISSN: 0065-1435


  23 in total

1.  Homozygous deletion of INK4a/ARF genes and overexpression of bcl-2 in relation with poor prognosis in immunocompetent patients with primary central nervous system lymphoma of the diffuse large B-cell type.

Authors:  Y Hayashi; M Iwato; Y Arakawa; H Fujisawa; Y Thoma; M Hasegawa; O Tachibana; J Yamashita
Journal:  J Neurooncol       Date:  2001-10       Impact factor: 4.130

2.  An unusual presentation of primary malignant B-cell-type dural lymphoma.

Authors:  Yin Yee Sharon Low; Siang Hui Lai; Wai Hoe Ng
Journal:  Singapore Med J       Date:  2014-11       Impact factor: 1.858

3.  Serial cerebrospinal fluid examinations to diagnose hematological malignancy causing neurological disease.

Authors:  Eugene L Scharf; Curtis A Hanson; Matthew T Howard; B Mark Keegan
Journal:  J Neurooncol       Date:  2016-05-09       Impact factor: 4.130

4.  Primary intracerebral Hodgkin's lymphoma.

Authors:  T P Doorly; M A Farrell; J Phillips
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-08       Impact factor: 10.154

5.  Proceedings of the congress of the Società Italiana di Neurochirurgia, Bari, September 20-October 1st, 1983. Abstracts.

Authors: 
Journal:  Acta Neurochir (Wien)       Date:  1984       Impact factor: 2.216

6.  Cerebral lymphoma: clinical radiological correlation.

Authors:  J A Spillane; B E Kendall; I F Moseley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-03       Impact factor: 10.154

7.  Primary central nervous system lymphoma in Japan--a retrospective, co-operative study by CNS-Lymphoma Study Group in Japan.

Authors:  T Hayakawa; K Takakura; H Abe; T Yoshimoto; R Tanaka; K Sugita; H Kikuchi; T Uozumi; T Hori; H Fukui
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

8.  Ki-1 positive meningeal lymphoma in a patient with a history of Hodgkin lymphoma.

Authors:  M Serena; G Tonetto; P Belli
Journal:  Ital J Neurol Sci       Date:  1991-02

9.  Involvement of the central nervous system in malignant lymphomas.

Authors:  K Jellinger; T Radiaszkiewicz
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1976-07-21

10.  CNS manifestations in non-Hodgkin lymphomas (NHL).

Authors:  M Freund; P Ostendorf; V H Gärtner; H D Waller
Journal:  Klin Wochenschr       Date:  1983-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.